Grantham Mayo Van Otterloo & Co. LLC Sells 115,845 Shares of Houlihan Lokey, Inc. (NYSE:HLI)

Grantham Mayo Van Otterloo & Co. LLC reduced its position in shares of Houlihan Lokey, Inc. (NYSE:HLI - Free Report) by 39.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 178,136 shares of the financial services provider's stock after selling 115,845 shares during the period. Grantham Mayo Van Otterloo & Co. LLC owned approximately 0.26% of Houlihan Lokey worth $30,935,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in HLI. Private Trust Co. NA acquired a new position in shares of Houlihan Lokey during the 4th quarter worth $29,000. Financial Life Planners acquired a new position in Houlihan Lokey during the fourth quarter worth about $33,000. Golden State Wealth Management LLC acquired a new position in Houlihan Lokey during the fourth quarter worth about $53,000. VisionPoint Advisory Group LLC bought a new position in shares of Houlihan Lokey in the fourth quarter worth about $62,000. Finally, Quarry LP acquired a new stake in shares of Houlihan Lokey in the 3rd quarter valued at approximately $76,000. 78.07% of the stock is currently owned by institutional investors.

Houlihan Lokey Price Performance

NYSE HLI traded down $0.62 on Friday, reaching $149.53. The company had a trading volume of 116,298 shares, compared to its average volume of 348,374. The firm has a market cap of $10.49 billion, a price-to-earnings ratio of 28.51 and a beta of 0.84. Houlihan Lokey, Inc. has a fifty-two week low of $122.14 and a fifty-two week high of $192.10. The business has a 50 day moving average of $165.47 and a two-hundred day moving average of $172.20.

Remove Ads

Houlihan Lokey (NYSE:HLI - Get Free Report) last issued its quarterly earnings results on Tuesday, January 28th. The financial services provider reported $1.64 earnings per share for the quarter, beating the consensus estimate of $1.51 by $0.13. Houlihan Lokey had a return on equity of 20.04% and a net margin of 16.00%. As a group, research analysts predict that Houlihan Lokey, Inc. will post 5.98 earnings per share for the current fiscal year.

Houlihan Lokey Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Saturday, March 15th. Shareholders of record on Monday, March 3rd were issued a dividend of $0.57 per share. The ex-dividend date was Monday, March 3rd. This represents a $2.28 annualized dividend and a yield of 1.52%. Houlihan Lokey's payout ratio is 43.51%.

Analysts Set New Price Targets

HLI has been the subject of a number of research analyst reports. StockNews.com cut shares of Houlihan Lokey from a "buy" rating to a "hold" rating in a research report on Tuesday, February 25th. JPMorgan Chase & Co. dropped their price target on Houlihan Lokey from $172.00 to $169.00 and set a "neutral" rating for the company in a research note on Wednesday, January 29th. Keefe, Bruyette & Woods reissued a "market perform" rating and set a $192.00 price objective (up previously from $170.00) on shares of Houlihan Lokey in a report on Wednesday, January 29th. Morgan Stanley lowered their target price on Houlihan Lokey from $190.00 to $156.00 and set an "overweight" rating for the company in a report on Monday. Finally, JMP Securities reissued a "market perform" rating on shares of Houlihan Lokey in a research note on Wednesday, January 29th. Four analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. Based on data from MarketBeat, Houlihan Lokey has a consensus rating of "Hold" and an average price target of $183.40.

Houlihan Lokey Company Profile

Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.